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Introduction: Our recent study indicated that subchondral bone pathogenesis in osteoarthritis (OA) is associated
with osteocyte morphology and phenotypic abnormalities. However, the mechanism underlying this abnormality
needs to be identified. In this study we investigated the effect of extracellular matrix (ECM) produced from normal
and OA bone on osteocytic cells function.
Methods: De-cellularized matrices, resembling the bone provisional ECM secreted from primary human
subchondral bone osteoblasts (SBOs) of normal and OA patients were used as a model to study the effect on
osteocytic cells. Osteocytic cells (MLOY4 osteocyte cell line) cultured on normal and OA derived ECMs were
analyzed by confocal microscopy, scanning electron microscopy (SEM), cell attachment assays, zymography,
apoptosis assays, qRT-PCR and western blotting. The role of integrinβ1 and focal adhesion kinase (FAK) signaling
pathways during these interactions were monitored using appropriate blocking antibodies.
Results: The ECM produced by OA SBOs contained less mineral content, showed altered organization of matrix
proteins and matrix structure compared with the matrices produced by normal SBOs. Culture of osteocytic cells on
these defective OA ECM resulted in a decrease of integrinβ1 expression and the de-activation of FAK cell signaling
pathway, which subsequently affected the initial osteocytic cell’s attachment and functions including morphological
abnormalities of cytoskeletal structures, focal adhesions, increased apoptosis, altered osteocyte specific gene
expression and increased Matrix metalloproteinases (MMP-2) and −9 expression.
Conclusion: This study provides new insights in understanding how altered OA bone matrix can lead to the
abnormal osteocyte phenotypic changes, which is typical in OA pathogenesis.Introduction
Bone matrix serves as an organized framework for bone
as a tissue, offering mechanical support and mediating
biological activities of bone cells and signals that main-
tain bone homeostasis and remodelling [1]. Bone cells,
like most other matrix-associated cells, cannot survive
or differentiate without adhesion to their matrix [2,3].
Consequently, bone cell morphology and functions can
depend strongly on matrix quality under conditions in
which biological signals are constant. In osteoarthritis* Correspondence: i.prasadam@qut.edu.au
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reproduction in any medium, provided the or(OA) it is well-known that subchondral bone matrix,
structure, organisation, composition and mineralisation
are abnormal when compared to normal bone [4].
Osteocytes are the most abundant and longest-
living cells in the adult skeleton. The importance of
osteocytes in regulating bone remodeling and turn-
over has been generally acknowledged [5]. Our re-
cent study demonstrated that various functional and
morphological properties of osteocytes appear to be
hampered in patients with OA, indicating that these
cells could play an important pathological role in
subchondral bone sclerosis [6]. However, the poten-
tial molecular mechanism behind this abnormalral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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identified.
In vivo, osteocyte cells under normal conditions, con-
tact a complex mixture of secreted ‘extracellular matrix’
(ECM) proteins called the bone matrix. The bone matrix
isolates osteocytes from each other and instead osteo-
cytes interact with other osteocytes and other bone cells
by an elaborate network of osteocytes (dendritic) pro-
cesses. The contact with the bone matrix is a critical
mechanism providing cues via cytoplasmic processes
called canalicules to form a cellular network to sense ef-
ficiently both mechanical and systemic stimuli [7]. On
the other hand, it seems that osteocytes which become
transformed in diseases such as osteoporosis and OA
are characterised by loose contact with ECM substrate
leading to morphological and functional bony changes
[6,8]. Primarily based on our previous observations, in
this study we hypothesised that altered mineralisation
and the ECM quality of the subchondral bone matrix is
the trigger for the osteocyte abnormalities seen in OA.
In vivo cell adhesion to the ECM is mediated by
integrinβ1 receptors. Bone ECMs are composed of se-
veral macromolecules including fibronectin, laminin,
collagens and proteoglycans. A number of these ECM
proteins contain the three amino acid sequence Arg-
Gly-Asp (RGD), which is exclusively recognised by cor-
responding integrinβ1 receptors [9,10]. Attachment of
integrins with the above macromolecules can activate
the downstream signalling focal adhesion kinase (FAK)
and vinculin that can initiate a cascade of phosphory-
lation events that fine-tune cell-type-specific phenotypes
[11]. Maintenance of integrin linkages is essential for cell
adhesion, proper cytoskeletal organisation and function
of the specific cell types. It has been demonstrated pre-
viously that disruption of these attachments, via addition
of neutralising antibodies or peptides, can induce cells
to detach from the ECM resulting in apoptosis, struc-
tural alterations and cellular dysfunction. The aim of this
study is to test how normal and OA bone ECM differen-
tially regulates the function of the osteocytes. The other
objective of the present study is to reveal the critical role
of cell-matrix adhesions governing this process, notably
involving the integrinβ1-FAK signalling axis.
Methods
Subchondral bone osteoblast (SBO) isolation and
characterisation
The Ethics Committee of Queensland University of
Technology and the Prince Charles Hospital approved
this study and the participants’ written consent was
obtained according to the Declaration of Helsinki (Ethics
Number: 0700000157). Knee bone specimens were taken
within 5 mm of the subchondral bone plate as described
previously in our studies [12-14]. OA SBOs were culturedfrom bone sourced from the medial compartment of the
knee from patients suffering advanced OA, where the car-
tilage was degraded and showed prominent subchondral
bone sclerosis and density (n = 5) (age: 61.5 ± 4 years).
Normal SBOs were cultured from bone collected from
trauma patients who were undergoing above the knee
amputations with no evidence of subchondral bone
sclerosis or cartilage degeneration on top of it (n = 4)
(age: 60.1 ± 6 years). The criteria for the OA diagnosis
were those established according to the American College
of Rheumatology [15]. None of the normal patients had
any musculoskeletal disorders, such as osteoporosis. SBOs
were isolated according to the method described by
Beresford [16,17]. Isolated normal and OA SBOs were
characterised for their phenotype as described in our pre-
vious studies [12,13]. Passage one SBOs were used for this
study.
Subchondral bone osteoblast differentiation and
preparation of de-cellularised matrices
Osteogenic differentiation of normal and OA SBOs
(20,000 cells per well) was performed in (D)MEM medium
containing osteogenic supplements (10 nM dexame-
thasone, 10 mM β-glycero-phosphate, 50 μg/mL ascorbic
acid) on coverslips (NUNC, Roskilde, Denmark) (placed
on 24 well plates) for five weeks. After five weeks, SBOs
were rinsed two times in 1X PBS. Next, to produce the
de-cellularised matrices, 0.02 M ammonium hydroxide in
ddH2O was applied for 20 to 30 minutes at room
temperature intermittently visualising under a light micro-
scope for cell roundup and lysis. Then ammonium hy-
droxide was removed by inverting the culture surface,
with plates washed several times with sterile 1X PBS
before seeding osteocytes on top of them.
Characterisation of de-cellularised matrices
The removal of cells and the retention of a collagenous
matrix were verified following de-cellularisation. Briefly, cells
were fixed in 4% paraformaldehyde for ten minutes, washed
three times with 1X PBS and permeabilised with 0.1% Tri-
ton for five minutes and stained with ProLong Gold
Antifade Reagent (Invitrogen, Life Technologies Australia
Pty Ltd, Victoria, Australia) with 4',6-diamidino-2-
phenylindole (DAPI) on a glass slide. The absence of nuclei
was confirmed using fluorescence microscopy (Zeiss, using
AxioVision Image analysis software). The presence of colla-
gen I and various ECM proteins in the de-cellularised matri-
ces was confirmed by immunostaining and western blotting
following the protocol described in our previous studies
[12,13]. The presence of mineral content was confirmed by
staining matrices with 1% alizarin red. Scanning electron mi-
croscopy (SEM) with energy dispersive X-ray analysis (SEM/
EDX) (FEI Quanta 200 Environmental SEM equipped with
an Evarhart Thomley secondary electron detector) was used
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posit and to obtain the elemental composition in normal
and OA matrices.
MLOY4 osteocyte cell line culture
The well-characterised osteocytic line, MLOY4 (provided
by Dr. Lynda Bonewald) [18] was cultured on T75 tissue
culture flasks coated with type I collagen (0.30 mg/ml;
Sigma, St. Louis, MO, USA) in osteocyte culture medium
containing alpha modified essential medium (αMEM;
GIBCO BRL, Grand Island, NY, USA), 5% fetal bovine
serum (FBS; Hyclone, Logan, UT, USA), 5% calf serum
(CS), and 1% penicillin and streptomycin (GIBCO BRL).
Seeding MLOY4 cells on normal and osteoarthritis
matrices
MLOY4 cells (10,000 cells/cover slip) were seeded directly
on the top of the normal and OA matrices prepared above
and incubated in osteocyte medium at 37°C containing 5%
CO2/95% atmospheric air at different time points.
Integrin and focal adhesion kinase signalling studies
To confirm the integrinβ1 mediated molecular mecha-
nism, MLOY4 cells were cultured on normal and OA
matrices in the presence or absence of blocking-integrinβ1
(10 μm) antibody (Clone P5D2, Chemicon, Millipore,
MERCK Pvt Ltd, Victoria, Australia) or with an irrelevant
antibody. P5D2 react with the human β1 integrin subunit
and block adhesion of cells to ECM proteins. FAK activa-
tion and de-activation was analysed by anti-phospho- FAK
and anti-total FAK antibodies (Cell Signaling Technology,
Gene search Pty Ltd, Queensland, Australia).
Scanning electron microscopy
The morphology of osteocytes grown on normal and OA
osteoblast matrices were assessed by SEM as described pre-
viously [19]. (+/− MLOY4 cells) were fixed with a solution
containing 3% (v/v) glutaraldehyde in 0.1 M sodium caco-
dylate buffer solution (pH 7.3) for one hour at 4°C and
postfixed in 1% osmium tetroxide for one hour. The
samples were dehydrated in increasing concentrations of
ethanol (from 50%, 70%, 90% to 100%) and were critical-
point-dried. Cover slips were mounted on aluminium stubs
before being sputter coated with a thin layer of gold in a
SC500, Bio-Rad sputter coater (Bio-Rad, BioRad Laborator-
ies Pty Ltd, New south wales, Australia) before examination
using a FEI Quanta 200 scanning electron microscope (FEI,
Hillsboro, OR, USA). Backscatter imaging on in vivo sam-
ples was performed as described previously [6].
Immunoflouresence
To examine focal adhesion formation and cytoskeletal
organisation, osteocytes cultured on normal and OA
ECM substrates were fixed in 4% paraformaldehyde(pH 7.4 in PBS) for 10 minutes, and then permeabilised
with 0.2% Triton X-100 for 10 minutes. After washing
and blocking with 1% BSA, cells were incubated with
primary antibody vinculin 5 μg/ml (Sigma Aldrich, New
south wales, Australia), SOST 5 μg/ml (R&D Systems,
Sapphire Biosciences Pty Ltd, New south wales,
Australia), DMP1 5 μg/ml (gift from Professor Jian Feng)
and E11 5 μg/ml at 4°C overnight followed by secondary
antibody (Alexa Fluor 488-labeled goat anti mouse im-
munoglobulin G (IgG), Invitrogen) incubation. F-actin
distribution was visualised using Alexa Fluor 568 nm-
labeled phalloidin (Invitrogen) staining. The samples
were washed with 1X PBS three times, blown dry with
air and mounted with Prolong Gold antifade solution
containing DAPI for cellular nuclei staining and fluores-
cence preservation. Samples were then visualised using
a DeltaVision PDV microscopy system equipped with an
Olympus IX70 inverted microscope (Olympus). After
acquisition of the Z-series images, they were
deconvolved using the software attached in the system
(Softworx; Applied Precision). The shapes of the fluor-
escent signals in osteocytes cultured on the normal and
OA matrix were analysed using the integrated morph-
ometry shape factor analysis of Metamorph software
version 7.1.2 (Universal Imaging). This algorithm as-
signs a value from 0 to 1, describing the shape of the
fluorescence signal where a perfect circle attains a value
of 1 and a line is assigned a 0.
Cell attachment assays
MLOY4 cells were seeded directly on normal and OA
matrices with a seeding density of 10,000 viable cells per
well. Cells were allowed to attach in the humidified incuba-
tor for two different time periods, 3 and 24 hours. At the
end of each culture period cells were stained for 10 minutes
with 0.2% crystal violet (Sigma) in 20% methanol. After
washing with H2O, plates were dried overnight at room
temperature. Cells were dissolved in 1% SDS (150 μl), and
the absorbance at 570 nm was measured.
Cell proliferation assays
Cell proliferation was determined using the CyQUANT NF
Cell Proliferation Assay Kit (Molecular Probes, Invitrogen)
at 48 hours of MLOY4 cell culture on normal and OA
matrices according to the manufacturer’s instructions.
Plates were then analysed by using a microplate reader (ex-
citation: 485 nm, emission: 520 nm).
Apoptosis assays
The viability of MLOY4 cells was quantified by flow cy-
tometry with the AnnexinV-FLOUOS apoptosis staining
kit (Roche Applied Science, Germany, Roche Australia
PVT LTD, New south wales, Australia) following the
manufacturer’s protocol.
Figure 1 (See legend on next page.)
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Figure 1 Confirmation of de-cellularisation in osteoblast secreted matrices. (A) Light microscopy (scale bar = 100 μm) and SEM techniques
were performed following the de-celluarisation of normal matrices. Non de-celluarised osteoblasts are shown as controls. (scale bar: 20 μm). DAPI
staining of de-cellularised matrices show no nuclear remnants and non de-cellularised matrices show intact nuclei (scale bar: 50 μm). (B) DNA
analysis of the normal osteoblast derived matrices confirmed the removal of nucleic acids in the lysates of de-cellularised matrices. (C, D) Alizarin
red staining and the EDX technique were performed to see the mineral content of the normal and OA de-cellularised matrices. All results
(from A to D) are representative of matrices produced from four different patients each time with two replicates. Non DCM: Non de-cellularised
matrix; DCM: de-cellularised matrix. DAPI, 4',6-diamidino-2-phenylindole; EDX, energy dispersion X-ray; OA, osteoarthritis; SEM, scanning
electron microssopy.
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western blotting
qPCR, zymography and western blotting techniques
were performed as described in our previously published
studies [12-14,20].
Statistical analysis
Comparisons between groups were carried out by Stu-
dent’s t-test and for multiple comparisons analysis of va-
riance (ANOVA) was used where P ≤0.05 was considered




Light microscopy and SEM analysis of de-cellularised
normal matrices confirmed the intact architecture and
absence of cells following the processing. Nuclear rem-
nants could not be detected by DAPI staining, indicat-
ing satisfactory de-cellularisation of osteoblasts leaving
the intact matrices. Non de-cellularised matrices were
observed in parallel, showing the cell nuclear staining
(Figure 1A). The absence of DNA in the matrix lysates
further confirmed that approximately 99% of the DNA
was removed by the de-cellularisation process (Figure 1B).
Alizarin red staining confirmed the presence of mine-
ralisation nodules after de-cellularisation (Figure 1C). Fur-
thermore, EDX showed clear peaks for both phosphorus
and calcium confirming the presence of calcium phos-
phate in the de-cellularised matrices obtained from the
osteogenic culture of SBOs (Figure 1D). Hence, based on
these results, we determined that the de-cellularisation
protocol produced an acellular matrix scaffold that retains
the gross, microstructural, and ultrastructural properties
of the native bone tissue ECM microenvironment.
Characterisation of ECM secreted by normal and OA
osteoblasts
First, at the gene level, bone regulating genes such as
runt-related transcription factor (RUNX2), osteocalcin
(OCN), alkaline phosphatase (ALP) and bone sialoprotein
(BSP) were up-regulated in OA osteoblasts compared with
normal osteoblasts (Figure 2A). Furthermore, matrix min-
eralisation of normal osteoblasts was higher compared toOA osteoblasts (Figure 2B). Immunoblotting was
performed on the normal and OA derived de-cellularised
matrices to address changes in ECM constitution specifi-
cally focussing on bone matrix RGD glycoproteins (which
specifically recognise integrins). The expression of fibro-
nectin (FN), versican and laminin (LN) was significantly
higher in normal osteoblast derived matrices compared to
OA osteoblast derived matrices. Surprisingly, the largest
amounts of osteopontin (OPN) were present in OA osteo-
blast derived matrices compared to normal. COLIII was
detectable in both normal and OA matrices; however this
molecule did not show a significant difference (Figure 2C
to G). These results demonstrate that the ECM derived
from normal and OA osteoblasts were different with re-
spect to its composition. After five weeks of osteogenic
differentiation, SEM and type I collagen (COL1) immuno-
staining analysis demonstrate that the de-cellularised
matrix formed by the OA osteoblasts had a less preserved
matrix organisation and alignment compared to normal
matrix. In accordance with the results obtained from the
in vitro studies, matrix mineral distribution was disor-
ganised, showing a woven appearance in tibial severe OA
subchondral bone derived from patients undergoing knee
replacement surgery (Figure 2H).
Differential cell-matrix adhesions regulate morphology of
osteocytic cells scattered within the normal and
osteoarthritis osteoblast derived extracellular matrix
The morphology of osteocytic cells cultured on nor-
mal and OA osteoblast derived ECMs was examined
via light microscopy, SEM analysis and confocal mi-
croscopy. First, basic microscopic observations of
osteocytic cell populations revealed striking morpho-
logical differences when grown on normal and OA
matrices. Osteocytic cells that were cultured on OA
matrix typically displayed a round morphology, tended
to have less protrusive extensions and their cytoplasm
was wider. On the other hand, osteocytic cells that
were gown on normal matrix exhibited a narrow and
elongated dendritic morphology. Similarly, Alizarin
red combined with haematoxylin staining revealed
well organised osteocytic cells in the normal bone
matrix compared to OA (Figure 3A). Based on these
preliminary differences, SEM was used to further
Figure 2 Distribution of matrix secreted by normal and OA osteoblasts. (A) mRNA levels of bone regulating genes in primary normal and
OA subchondral bone osteoblasts (SBOs) at passage one. Values were normalised to 18srRNA and GAPDH mRNA levels (n = 5 subjects).
(B) Normal and OA SBOs were cultured in osteogenic differentiation medium. After de-cellularisation matrix mineralisation was determined by
Alizarin red. Images were taken at 20X magnification. Total staining density of each well was quantified using ImageJ software (n = 3 subjects).
(C to G) Immunoblotting of FN, versican, LN, OPN and COLIII, in normal (NM) and OA osteoblast derived matrices (OA-M). Band density was
quantified using Image J software (n = 3 subjects). (H) SEM micrographs and COL1 immunostaining showing the morphology of matrix
organisation secreted by normal and OA osteoblasts. Note the poor alignment of OA osteoblast secreted matrix (n = 3 subjects). Scale bar:
100 μm. In vivo evidence of disrupted bone matrix in OA patients as determined by the back scatter SEM (BS-SEM) image technique. Scale bar:
200 μm and 100 μm. Results are shown as mean ± SD, * P ≤0.05 (Student t-test).
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that the osteocytic cells grown on the normal matrix re-
vealed a dense network of dendrites, adhesion to the
matrix surface and interaction between cells, whereas the
cells that were grown on the OA matrices revealed round,
rough and lysed morphology with poor dendrite forma-
tion and matrix alignment. We next examined the in vivo
morphology of osteocytes in the OA subchondral bone
derived from knee replacement surgeries. SEM revealed
that the osteocytes in OA samples were markedly de-
formed with a rough, lysed and rounded appearance with
very few dendrites compared to spindle shaped, well
organised and well connected osteocytes in the relatively
normal specimens, closely resembling the results obtained
from the in vitro cultures as shown above. These resultssuggest that we could closely mimic the in vivo osteocyte
and matrix interactions using the de-cellularised matrices
(Figure 3B).
These differences in morphology suggest underlying
differences in the organisation of the respective cytoske-
letons. Osteocytic cells that were grown on normal
matrix had straight actin fibres, which were visualised by
phalloidin. When the cells were grown on the OA
matrix, actin filament fibres were observed randomly
and visually no fibres were present at the center of the
osteocytic cells (Figure 3C).
The formation of focal adhesion complexes is a
prerequisite for cell-ECM adhesion. Therefore, it is
possible that the altered cell morphology capabilities
of osteocytic cells on the OA matrix may result from
Figure 3 (See legend on next page.)
Prasadam et al. Arthritis Research & Therapy 2013, 15:R150 Page 7 of 14
http://arthritis-research.com/content/15/5/R150
(See figure on previous page.)
Figure 3 Morphological changes of osteocytic cells in response to normal and OA osteoblast-derived matrices. (A) Cells cultured in 2D
showed rounded osteocyte morphology when grown on the OA matrices. Alizarin red combined with the haematoxylin staining showed a well
aligned osteocytic cell distribution within normal matrix (NM) compared to OA matrix (OA-M). Magnification: 20X. (B) SEM (Scale bar: 100 μm for
higher and 20 μm for lower magnification) and (C) confocal images (Scale bar: 50 μm for higher and 25 μm for lower magnification) indicated
diversified morphologies of osteocytic cells grown on OA osteoblast derived matrices. Actin filaments are shown in red, microtubules in green
and the nuclei in blue. (D) Representative micrographs of vinculin immunofluorescence (green) staining in osteocytic cells grown on normal and
OA matrices. Scale bars: 25 μm. (E) Shape factor analysis of the confocal images (phalloidin only) was performed with the Metamorph software.
At least 15 cells from three different experiments were analyzed. All images and graphs (A-E) are representative of experiments performed on
osteocytic cells that were grown on four different normal and OA patient-derived matrices. Results are shown as mean ± SD. Student’s t test,
P <0.05.
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immunofluorescence staining to examine the expres-
sion of focal adhesions. As shown in Figure 3D,
osteocytic cells grown on normal matrices formed
multiple focal adhesion structures at plasma mem-
branes and cytoplasm, as visualised by staining for
vinculin, an abundant cytoskeleton protein localised
at focal adhesions. In marked contrast, osteocytic
cells on an OA matrix showed fewer focal adhesion
contact points. Confocal images of osteocytic cells
shown in Figure 3C were quantitatively analysed for
shape factor. Cell shape factor changed from 0.1 to
0.4, indicating a transformation from a non-circular
spreading pattern as the cells developed spindle
shaped morphology to a rounded/circle pattern when
grown on an OA matrix (Figure 3E).
Altered functional and gene expression characteristics of
osteocytic cells grown on osteoarthritis osteoblast-
derived matrices
To understand the regulation of osteocyte function on the
normal and OA matrices, we compared osteocyte specific
gene expression, cell attachment, apoptosis and
Matrix metalloproteinases (MMP-2) and −9 production.
Using real-time PCR, we analysed a panel of characteristic
osteocyte markers after 48 hours of osteocytic cell culture
on normal and OA matrices. We observed that the expres-
sion of matrix extracellular phosphoglycoprotein (MEPE)
and E11 were upregulated significantly when osteocytic
cells were grown on OA matrices. On the other hand, the
expression of phosphate-regulating gene with homology to
endopeptidases on X chromosome (PHEX) remained at
similar levels with no differences between normal and OA
matrices. In contrast, DMP1 and SOST were significantly
downregulated in osteocytic cells that were cultured on the
OA matrices compared to those that were grown on nor-
mal matrix. (Figure 4A to E). Of note, although the MLOY4
cell line is a very powerful tool for the study of osteocytes
in vitro [21-23], there are known differences between pri-
mary osteocytes and the immortalised MLOY4 cell line.
For example, MLOY4 cells express low levels of DMP1 and
SOST, while osteocytes are known to express these genes
in vivo [24,25]. In this study, we observed that MLOY4 cellscultured on the collagen I coated flasks expressed relatively
low levels of dentin matrix protein 1 (DMP1) and sclerostin
(SOST) (data not shown); however, when these cells were
grown on the normal and OA matrices we found a signifi-
cant increase in the expression of these proteins compared
to those grown on the COL1 coated flasks. These results
suggest that the embedding of MLOY4 cells in the
mineralised matrices may significantly enhance the expres-
sion of these mature osteocyte markers, closely mimicking
the native bone matrix osteocyte phenotype. Confocal mi-
croscopy imaging of the DMP1, SOST and E11 demon-
strated trends similar to those seen at the gene expression
(Figure 4F, G,H) level. When the ability of cell attachment
was compared between normal and OA matrices, at three
hours osteocytic cells on normal and OA matrices had set-
tled onto their respective substrates and had a rounded
morphology (data not shown). However, at 24 hours the
osteocytic cells were attached more on normal matrix com-
pared to those that were grown on the OA matrix as deter-
mined by the crystal violet adhesion assay (Figure 4I).
Because we observed a lysed morphology of osteocytic cells
on the OA matrix, we compared the expression of MMP-2
and MMP-9 by zymography as these molecules are well
known to be involved in cell–matrix adhesions. We found
higher levels of MMP-2 and MMP-9 in cells that were cul-
tured on the OA matrices (Figure 4J). Furthermore, osteo-
cytic cells exposed to OA bone matrix appeared to be more
sensitive to apoptosis than those cultured on the normal
matrices (Figure 4K).
Expression of integrinβ1-FAK signalling in osteocytic cells
cultured in normal and osteoarthritis bone matrices
In immunohistochemistry analysis, in vivo osteocytes in
relatively normal human subchondral bone expressed
higher levels of integrinβ1 compared to osteocytes from
OA patients, indicating the altered expression of this mol-
ecule in OA osteocytes. This downregulation of integrinβ1
protein expression in human OA bone tissue lysate was
further confirmed by immunoblotting (Figure 5A,B). Fur-
thermore, the expression of integrinβ1 was significantly
higher in osteocytic cells that were grown on the normal
matrices compared to OA matrices (OA-M). On the other
hand, the expression levels of αVβ5 and αVβ3 integrins
Figure 4 (See legend on next page.)
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Figure 4 Functional and gene associated changes of osteocytic cells (OT) in response to normal (NM) and OA osteoblast derived
matrices (OA-M). (A to E) Gene expression profiles of osteocyte markers were determined by qRT-PCR in osteocytic cells cultured either on
normal or OA matrices for 48 hours. The results are expressed as relative gene expression after normalization using the 18srRNA and GAPDH
housekeeping gene. (F to H) Protein localisation of DMP1, SOST and E11 osteocyte markers was determined by confocal microscopy (Scale bar:
50 μm for higher and 25 μm for lower magnification). (I) Cell adhesion of osteocytic cells cultured on normal and OA matrices was determined
by staining with crystal violet. (J) Zymographic analysis shows the expression of MMP2 and MMP9 in osteocyte conditioned media collected after
24 hours of incubation after culturing on normal and OA matrices. (K) The flow cytometric apoptosis analysis of osteocytic cells on normal and
OA matrices was determined by Annexin V/PI staining. All images and graphs are representative of experiments performed on osteocytic cells
cultured on matrices derived from four different normal and OA patients. Results are shown as mean ± SD, * P ≤0.05 by Student’s t-test.
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Integrinβ1 can serve as an important regulator of down-
stream signalling. We, therefore, examined modifications
of the intracellular signalling cascade in osteocytic cells
after exposure to normal and OA matrices. The expe-
riments concentrated on FAK signalling pathways which
are known to be involved in cell-matrix regulation. Also,
compared to the OA matrices the osteocytic cells cultured
on normal matrices evoked upregulation of FAK phos-
phorylation (Figure 5D). Furthermore, integrinβ1 inhibition
using blocking antibodies led to FAK dephosphorylation
even when osteocytic cells were cultured on normal ma-
trices indicating that the phosphorylation of FAK was
dependent on integrinβ1 activation (Figure 5E).Figure 5 Expression of integrinβ1(INT-β1) - FAK signalling in osteocyt
Immunohistochemical and western blot analysis shows a decrease in the p
bone compared to normal bone collected from the human tibia. Images a
patients. (C, D) Western blot analysis of integrinβ1, αVβ5 and αVβ3 and FA
(OA-M) compared to normal matrices (NM). Band density graphs are repres
matrices. Results are shown as mean ± SD, * P ≤0.05 by Student’s t-test. (E
osteocytic cells cultured on the normal matrices (NM). Images and graphs
developed from normal and OA osteoblasts. Results are shown as mean ±Integrinβ1 blocking diminished phenotypic and
genotypic capacity of osteocytic cells attached on the
normal matrices
Next we examined the relevance of integrinβ1 in media-
ting the phenotypic and genotypic responses of osteocytic
cells cultured on the normal matrices by using blocking
antibodies. In this context, as determined by SEM and
confocal microscopy, the morphology of osteocytic cells
grown on normal matrices in the presence of integrinβ1
blocking antibodies was drastically changed to a pheno-
type similar to cells that were grown on the OA matrices,
demonstrating a link between integrinβ1 and altered
osteocyte cell-matrix interaction (Figure 6A,B). Further-
more, osteocytic cell adhesion was decreased in theic cells grown on normal and OA matrix. (A, B)
ositively stained osteocytes (OT) for integrinβ1 in OA subchondral
re representative of the experiments performed on three different
K phosphorylation in osteocytic cells that were grown on OA matrices
entative of the experiments performed on three different patient
) Decreased phosphorylation of FAK upon blocking integrinβ1 in
are representative of experiments performed on three patient matrices
SD, * P ≤0.05 by Student’s t-test.
Figure 6 (See legend on next page.)
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addition, the osteocyte markers E11 and MEPE were
upregulated and genes, such as DMP1 and SOST, were
significantly downregulated upon blocking of integrinβ1(Figure 6D to G). Likewise, blocking antibodies against
integrinβ1 increased osteocyte apoptosis (Figure 6H) and
MMP production (Figure 6I). These results together sug-
gest an important role of integrinβ1 in mediating the
(See figure on previous page.)
Figure 6 Integrinβ1 (INT-β1) blocking disables the morphology and function of osteocytic cells cultured on normal matrices.
(A) SEM and confocal images illustrating distinct morphological changes induced by integrinβ1 blocking in osteocytic cells cultured on the
normal matrices (NM). (Scale bars: 50 μm). (B) Shape factor determined on the osteocytic cells cultured on normal matrices upon integrinβ1
blocking. (C) Cell adhesion determined on the osteocytic cells grown on the normal matrices upon integrinβ1 blocking (D to G) Gene expression
profiles of osteocyte markers as determined by qRT-PCR in the presence of integrinβ1 blocking antibodies on normal matrix. The results are
expressed as relative gene expression after normalisation using the 18srRNA and GAPDH housekeeping gene. (H) Osteocytic cells grown on the
normal matrices were treated with integrinβ1 blocking antibody and incubated for 24 hours, and then detection of apoptosis was performed by
flow cytometry. (I) Zymographic analysis shows the expression of MMP2 in osteocytic cell conditioned media collected after 24 hours of
incubation after culturing on normal matrices in the presence or absence of integrinβ1 blocking antibody. All images and graphs are
repremsentative of experiments performed on osteocytic cells cultured on matrices derived from three different normal patients. Results are
shown as mean ± SD, * P ≤0.05 by Student’s t-test.
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Discussion
It is now well accepted that joint cartilage degeneration
is associated with intensified remodelling of the sub-
chondral bone and increased bone stiffness [26]. Under-
standing which cells/molecules are involved in bone
sclerosis could help us find ways to manipulate such
molecules to slow down the progression of OA.
Earlier studies have shown that the de-cellularised
matrix produced by osteoblasts is able to induce attach-
ment and spreading of many adherent cell types, including
mesenchymal stem cells [27-29]. In principle, the use of
NH4OH leads to hypoxia and subsequent cell lysis leaving
the matrix intact. It is thus regarded as an in vitro model
to study the molecular basis of cell attachment, spreading
and signalling from the ECM. In the present study, we
confirmed that de-cellularised osteoblast matrices repre-
sent the in vivo bone matrix characterised by accumu-
lation of the mineral content and expression of various
collagenous and non-collagenous proteins, thus providing
the ideal environment to study cell-matrix interactions.
First, we observed significant differences in the mineral
content of matrices secreted by normal and OA osteo-
blasts. These results are in agreement with previous re-
ports suggesting the abnormally low mineralisation of OA
osteoblasts [30]. The present study also showed that hu-
man osteoblast ECM derived from primary bone cell cul-
tures has the capacity to produce a wide range of matrix
proteins. Surprisingly, we observed that the levels of fibro-
nectin, laminin and versican were decreased in OA ma-
trices compared to normal. In general, fibronectin is
presumed to contribute more to general structure and
load bearing [31], whereas versican and laminin interact
with other matrix components as well as with cell surface
adhesion receptors via well-defined domains [32]. Low
expression of these molecules is suggestive of abnormal
ECM composition in OA matrices. Previous studies
demonstrated an increase of COL1 in OA osteoblasts at
the cellular level [33]. In this study, the matrix deposited
by OA osteoblasts showed a dispersed COL1 stainingcompared to normal matrix. These results corroborate
the results of studies showing disorganised collagen
fibres in OA bone compared to normal [34]. Further-
more, although not statistically significant, we observed
that expression of OCN was higher in OA patients.
However, many other studies showed a significant in-
crease of OCN in OA patients [30,35]. This disparity in
the results could be attributed to biological variation,
process variation and system variation.
Based on the above results, it is apparent that the
ECM secreted by normal and OA osteoblasts is different.
We next tested whether these matrix differences can
contribute to the poor morphological and phenotypic
properties of osteocytes seen in OA bone. Our results
suggest that osteocyte cell lines, such as MLOY4, could
be altered in response to the ECM of OA osteoblasts
compared to the ECM generated from normal osteo-
blasts. At the gene expression level, when osteocytic cells
were grown on OA matrices a decrease in DMP1 and
SOST expression and an increase in E11 and MEPE ex-
pression were found. Although E11, MEPE, DMP1 and
SOST are known markers of the osteocyte, each gene
has a distinct function and their expression levels change
according to the specific stage of differentiation. Osteo-
cyte expression of SOST [36] and DMP [37] is a delayed
event and it is produced only by osteocytes after they be-
come embedded deeply in matrix that has been fully
mineralised. Our results showed that OA osteoblasts
failed to lay a proper mineral or matrix. Therefore, these
matrix properties might have influenced the behaviour
of osteocytes, stopping them from expressing those ma-
ture markers; whereas E11 and MEPE are early markers
and they start to express when osteocytes are in the
process of embedding into the matrix that is not fully
mineralised [38]. Failure of osteocytic cells to produce
these proteins when cultured on the OA matrix also
suggests a state of immature osteocytes. These results
together suggest that in OA matrices osteocytic cells
remained in an immature phenotype; however, when
they were cultured on the normal matrices, the osteo-
cytes differentiated from an immature to mature pheno-
type. Likewise, on the OA matrices an increase in
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related to increased skeletal fragility, linked to the loss of
ability to sense microdamage and/or signal repair of
in vivo bone [39].
The observation that the morphological and phenotypic
characteristics of osteocytic cells attached to the normal
and the OA matrices differ from each other, suggests that
specific signalling pathways must arise or alter between
matrix and cells. Of note, we observed that the expression
of integrinβ1 was much less in osteocytic cells that were
cultured on the OA matrices compared to normal matri-
ces indicating that the decrease of integrinβ1 expression
could be responsible for the observed phenotypic changes
of osteocytes in OA.
How and to what extent integrinβ1 is involved in the
transduction of a matrix signal to modulate osteocyte
function was investigated by a series of further expe-
riments. We found that the blocking integrinβ1 activity
promoted the elongated cell morphology to a rounded
phenotype even when osteocytic cells are cultured on nor-
mal osteoblast matrices. This series of events occurred via
the down regulation of FAK phosphorylation levels. The
effect of integrinβ1 blocking on cell morphology was pos-
sibly due to FAK signals leading to actin contractility
events and the dynamic regulation of viniculin. Normally,
integrinβ1-FAK signalling, apart from playing a role as a
hook to attach the cell to matrix, generates a signal to
enforce the cell towards functions such as attachment,
apoptosis and differentiation. In this study, we observed
that osteocytic cells on OA matrices and integrinβ1
blocking showed an increased apoptosis and altered osteo-
cyte gene expression, indicating that the expression of
integrinβ1-FAK signalling is important to maintain the
normal osteocyte-matrix interactions. In vitro data pre-
sented here are consistent with results from an integrinβ1
negative mouse model in which mice exhibited less
mineralised bone, reduced tibial curvature and decreased
femoral strength [40]. Thus, this study provides evidence
that integrinβ1 may initiate intracellular signals either by
organisation of the cytoskeleton and alteration of cell
shape or through mechanisms akin to osteocyte signalling.
In this study, we observed that the expression of Vβ3 and
Vβ5 were not changed. Although different integrin recep-
tors perform common functions and can share identical
ligands, each member seems to be highly specific, since
mice carrying gene deletions of the different integrin
chains often show non-overlapping phenotypes [41]. We
are confident that there might be other integrins partici-
pating in the interaction and further studies are warranted
to determine their role.
Conclusion
In summary, this study demonstrated that ECM from OA
osteoblasts can induce significant alteration of osteocyticcells via a focal adhesion mediated integrinβ1-FAK cell
signalling pathway, a possible mechanism of OA sub-
chondral bone sclerosis and OA progression.
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